DIVA Laboratories, Ltd. (TPEX:4153)

Market Cap	1.76B -23.2%
Revenue (ttm)	884.63M +4.4%
Net Income	90.43M -4.0%
EPS	n/a
Shares Out	58.67M
PE Ratio	19.43
Forward PE	n/a
Dividend	1.48 (4.93%)
Ex-Dividend Date	Jun 13, 2025

Volume	49,548
Average Volume	55,230
Open	30.15
Previous Close	30.20
Day's Range	29.80 - 30.15
52-Week Range	29.80 - 43.95
Beta	0.21
RSI	22.65
Earnings Date	May 12, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 154
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4153

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.